PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia.

Autor: Tiberi G; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Pekowska A; CIML, CNRS UMR6102, INSERM U631, Aix-Marseille Université, Marseille, France., Oudin C; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Ivey A; 1] Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK [2] GSTS Pathology, Guy's Hospital, London, UK., Autret A; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Prebet T; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Koubi M; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Lembo F; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Mozziconacci MJ; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Bidaut G; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Chabannon C; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Grimwade D; Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK., Vey N; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Spicuglia S; CIML, CNRS UMR6102, INSERM U631, Aix-Marseille Université, Marseille, France., Calmels B; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Duprez E; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2015 May; Vol. 29 (5), pp. 1202-6. Date of Electronic Publication: 2014 Dec 08.
DOI: 10.1038/leu.2014.339
Databáze: MEDLINE